FSD Pharma Inc. (HUGE) –
-
FSD Pharma (HUGE) Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products
-
Form 6-K FSD Pharma Inc. For: Apr 16
-
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products
-
Form 6-K FSD Pharma Inc. For: Mar 29
-
FSD Pharma Inc. (HUGE) Provides Update on its Investment in Celly Nutrition Corp
-
Form 6-K FSD Pharma Inc. For: Apr 15
-
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption
-
Form 6-K FSD Pharma Inc. For: Apr 07
-
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Form 20-F FSD Pharma Inc. For: Dec 31
-
FSD Pharma Announces Filing of Year-End 2023 Results
-
FSD Pharma Inc. (HUGE) Signs the Agreement With iNGENu CRO to Conduct a Trial of Lucid-21-302
-
Form 6-K FSD Pharma Inc. For: Mar 26
-
FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults
-
FSD Pharma Inc. (HUGE) Submits a Phase-1b Trial Application for Ethics Committee for unbuzzd
-
FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM)
-
Form 6-K FSD Pharma Inc. For: Mar 08
-
FSD Pharma (HUGE) Presents Positive Results of Phase-1 study of Lucid-21-302
-
Form 6-K FSD Pharma Inc. For: Mar 04
-
FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
-
FSD Pharma (HUGE) Announces Debt Settlement
-
Form 6-K FSD Pharma Inc. For: Feb 27
-
FSD Pharma Announces Debt Settlement
-
FSD Pharma Inc. (HUGE) Signs Agreement With Ingenu CRO to Conduct a Trial of unbuzzd
-
Form 6-K FSD Pharma Inc. For: Feb 26
-
FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)
-
Form 6-K FSD Pharma Inc. For: Feb 29
-
Form 6-K FSD Pharma Inc. For: Feb 16
-
Form 6-K FSD Pharma Inc. For: Feb 29
-
Form 424B5 FSD Pharma Inc.
-
FSD Pharma Inc. (HUGE) Announces ATM Offering
-
FSD Pharma Announces US ATM Offering
-
Form 6-K FSD Pharma Inc. For: Jan 29
-
Form 6-K FSD Pharma Inc. For: Feb 05
-
FSD Pharma (HUGE) Announces Court of Appeal's Dismissal of Motion for Leave to Appeal Brought by Dr. Raza Bokhari
-
Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
-
FSD Pharma Inc. (HUGE) Appoints Sanjiv Chopra to its Board
-
FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates
-
Form 6-K FSD Pharma Inc. For: Jan 16
-
Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
-
GBB Drink Lab Provides Update on Lawsuit against FSD Pharma Inc. (HUGE)
-
GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
-
Form EFFECT FSD Pharma Inc.
-
Form 6-K FSD Pharma Inc. For: Dec 22
-
Form F-3 FSD Pharma Inc.
-
FSD Pharma (HUGE) Files Final Base Shelf Prospectus to Replace Expired Shelf
-
FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
-
Form 6-K FSD Pharma Inc. For: Dec 21
-
Form 6-K/A FSD Pharma Inc. For: Dec 18
-
Form 6-K FSD Pharma Inc. For: Dec 14
Back to HUGE Stock Lookup
